MCG
PFE icon

MACRO Consulting Group’s Pfizer PFE Stock Holding History

MACRO Consulting Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-38,294
Closed -$1.34M – 99
2020
Q1 		$1.34M Buy
38,294
+3,560
+10% +$121K 1.03% 37
2019
Q4 		$1.29M Buy
34,734
+132
+0.4% +$4.7K 1.02% 42
2019
Q3 		$1.18M Buy
+34,602
New +$1.26M 1% 42

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

MACRO Consulting Group's PFE Position: Q2 2020 in Review

MACRO Consulting Group sold out of Pfizer (PFE) in Q2 2020, closing a stake of 38,294 shares — an estimated $1.34M sold.

MACRO Consulting Group first reported a position in PFE in Q3 2019 and held it in 3 quarters. The position peaked at $1.34M in Q1 2020. 2,442 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

  • MACRO Consulting Group reported no remaining Pfizer position as of Q2 2020 after selling out during the quarter.
  • MACRO Consulting Group sold 38,294 Pfizer shares in Q2 2020, an estimated $1.34M.
  • MACRO Consulting Group first reported a position in Pfizer in Q3 2019 and held it in 3 quarters.
  • MACRO Consulting Group's Pfizer position peaked at $1.34M in Q1 2020.
  • 2,442 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on MACRO Consulting Group's 13F filing for Q2 2020, filed 10 Aug 2020.